Recent advances in our understanding of neurodegeneration
The DOI matches its Crossref record; 617 of the 618 references it cites were found in a registry or an index.
Abstract
Neurodegenerative diseases are featured by progressive dysfunction and death of cells in selected areas in the nervous system, determining clinical presentation. Neuronal loss is associated with conformational changes in proteins that result in extra- and intra-cellular accumulation of misfolded proteins, representing the hallmarks of many neurodegenerative disorders, summarized as proteinopathies. Intermediate forms such as oligomers and protofibrils are thought to have cytotoxic effects to neurons. Major basic processes, caused by genetic, environmental, and endogenous factors, in addition to abnormal protein dynamics with defective degradation due to deficiency of the ubiquitin-proteosomal-autophagy system, include oxidative stress and free radical formation, impaired bioenergetics and mitochondrial dysfunction, disruption of neuronal Golgi apparatus and transport, molecular chaperones, neurotrophins and "neuroinflammatory" processes. These mechanisms are interrelated in vicious circles finally leading to programmed cell death. A common feature of these conditions is a long run until sufficient protein accumulates, followed by a cascade of symptoms over many years with increasing disability leading to death. This provides a wide therapeutic window, especially in groups at risk identified early and preclinical diagnosis becomes feasible. Neurodegenerative disorders are classified according to known genetic mechanisms or to the major components of protein deposits. Although this has been a productive paradigm for the development of diagnostic consensus criteria, recent molecular biologic and genetic approaches have revealed that there are both overlap and intraindividual diversities between different phenotypes, related to synergistic mechanisms between major pathologic proteins (beta-amyloid, tau, alpha-synuclein, TDP-43), suggesting common pathogenic mechanisms. The nature, time course, and molecular causes of cell degeneration and demise, and the role of various pathogenic factors are a matter of considerable debate, but recent studies have provided insight into the basic processes in neurodegeneration and the roles of cell death programs common to this complex group of disorders, offering new ways for future prevention and treatment strategies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Amyloid-β plaques and hyperphosphorylated tau neurofibrillary tangles are common age-related lesions that are presumed to play primary pathophysiological roles in the dementia of Alzheimer’s disease (AD)(Jellinger, 2009).”
From Cellular, synaptic, and biochemical features of resilient cognition in Alzheimer’s disease (2013) · cites this paper as Jellinger, 2009
Citations
Cites
1 retracted
Items 401–600 of 617
Oxidative stress in neurodegeneration and available means of protection
Fatokun, A. A., Stone, T. W., & Smith, R. A. (2008) · Frontiers in bioscience · doi:10.2741/2926 · Cited by 109 · cited 2×
“many diseases including NDDs and their models (see Calabrese et al. 2007; Fatokun et al. 2008; Gardiner et al. 2009; Halliwell 2006; Nunomura et al. 2009; Petrozzi et al. 2007).”
BackgroundPrion protein misfolding and disease
Moore, R. A., Taubner, L. M., & Priola, S. A. (2009) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2008.12.007 · Cited by 108 · cited 2×
“The ‘‘toxic oligomer’’ hypothesis is supported by the finding that a single-domain antibody can recognize a common conformational epitope that is displayed by several disease-associated proteins, including b-amyloid (Ab), a-synuclein (aSyn), tau protein, prions, and polyglutamine (polyQ) containing peptides (Hernandez…”
BackgroundProteasome Regulators: Activators and Inhibitors
Huang, L., & Chen, C. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709787581860 · Cited by 108 · cited 1×
“Proteasome regulators (activators and inhibitors) have been reviewed recently (Huang and Chen 2009).”
BackgroundMitochondrial Dysfunction and Oxidative Stress in Parkinson’s Disease
Onyango, I. G. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9482-y · Cited by 108 · cited 1×
“Mitochondrial alterations and OS are important parts of the multifactorial pathogenic process of PD (Henchcliffe and Beal 2008; Muqit et al. 2006; Onyango 2008; Schapira 2008; Vila et al. 2008).”
BackgroundChapter 11 Autophagy in Neurite Injury and Neurodegeneration
Chu, C. T., Plowey, E. D., Dagda, R. K., Hickey, R. W., Cherra, S. J., & Clark, R. S. B. (2009) · Methods in Enzymology · doi:10.1016/s0076-6879(08)04011-1 · Cited by 107 · cited 1×
“Dysregulation of macroautophagy has been implicated in synaptic dysfunction, cellular stress, and neuronal cell death (Chu et al. 2009), while the process, known as microautophagy, is poorly understood (Rubinsztein 2006).”
BackgroundYu, Y., Kuo, C., Cheng, W., Liu, C., & Hsieh, M. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22011 · Cited by 107
Synaptic transmission block by presynaptic injection of oligomeric amyloid beta
Moreno, H., Yu, E., Pigino, G., Hernandez, A. I., Kim, N., Moreira, J. E., Sugimori, M., & Llinás, R. R. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900944106 · Cited by 107 · cited 2×
“Presynaptic injection of Ab blocks synaptic transmission (Moreno et al. 2009), while postsynaptic APP has recently been shown to enhance N-methyl D-aspartate (NMDA) receptors (Hoe et al. 2009).”
BackgroundThe Role of Amyloid-Beta Derived Diffusible Ligands (ADDLs) in Alzheimers Disease
Catalano, S., Dodson, E., Henze, D., Joyce, J., Krafft, G., & Kinney, G. (2006) · Current Topics in Medicinal Chemistry · doi:10.2174/156802606776743066 · Cited by 107 · cited 1×
“…of substances produced during early phases, and soluble oligomers and protofibrillar derivatives of misfolded proteins may play a pathogenic role (Catalano et al. 2006; Csizmók and Tompa 2009; Gong et al. 2003; Haass and Selkoe 2007; Hu et al. 2008; Irvine et al. 2008; Israeli and Sharon 2009;…”
BackgroundMitra, S., Tsvetkov, A. S., & Finkbeiner, S. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806269200 · Cited by 106 · cited 2×
“…of polyQ aggregates by the UPS is triggered by some nuclear Ub ligases (Iwata et al. 2009), and in inclusion bodies are suggested to have a protective cellular response to mhtt mediated in part by improving intracellular protein degradation related to impairment of UPS dynamics (Mitra et al. 2009).”
BackgroundThe p38 MAP kinase signaling pathway in Alzheimer's disease
Johnson, G. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00268-1 · Cited by 106 · cited 1×
“Stressactivated protein kinase pathways triggered by OS, are excessively activated in AD (Johnson and Bailey 2003; Petersen et al. 2007), even in early stages, deregulating cyclin-dependent kinase 5 (Cdk5), compromising the cellular antioxidant defense system and causing mitochondrial damage (Sun…”
BackgroundDefining the Role of Ubiquitin-interacting Motifs in the Polyglutamine Disease Protein, Ataxin-3
Berke, S. J. S., Chai, Y., Marrs, G. L., Wen, H., & Paulson, H. L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506084200 · Cited by 105 · cited 1×
“Ataxin-3 binds poly-Ub chains and acts as a deubiquitinating enzyme (Berke et al. 2005).”
BackgroundBoche, D., & Nicoll, J. A. R. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00134.x · Cited by 104 · cited 2×
“…tg animal models treated by immunotherapy causing plaque removal and increase in severity of cerebral amyloid angiopathy (CAA) (Boche et al. 2008; Boche and Nicoll 2008; Holmes et al. 2008; Prada et al. 2007; Wilcock et al. 2004; Wisniewski and Konietzko 2008) are not discussed here (see Foster…”
Distinct Pools of β-Amyloid in Alzheimer Disease–Affected Brain: A Clinicopathologic Study
Steinerman, J. R., Irizarry, M., Scarmeas, N., Raju, S., Brandt, J., Albert, M., Blacker, D., Hyman, B., & Stern, Y. (2008) · Archives of Neurology · doi:10.1001/archneur.65.7.906 · Cited by 104 · cited 2×
“The fraction of the soluble, mainly toxic Ab pool is intracellular (Steinerman et al. 2008) and is recognized and targeted by conformationsensitive antibodies (Meli et al.”
BackgroundGolgi apparatus and neurodegenerative diseases
Fan, J., Hu, Z., Zeng, L., Lu, W., Tang, X., Zhang, J., & Li, T. (2008) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2008.05.006 · Cited by 103 · cited 3×
“Fragmentation of the neuronal Golgi apparatus (GA) was reported in ALS, corticobasal degeneration, AD, PD, Creutzfeldt–Jakob disease, and in spinocerebellar ataxia type 2 (SCA2) (Fan et al. 2008).”
BackgroundInfluentialAxonal transport of synucleins is mediated by all rate components
Jensen, P. H., Li, J., Dahlström, A., & Dotti, C. G. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00754.x · Cited by 102 · cited 1×
“It is mainly transported in the slow, but a part also in fast transport (Jensen et al. 1999).”
BackgroundDeretic, V. (2008) · Methods in Molecular Biology™ · doi:10.1007/978-1-59745-157-4_1 · Cited by 102
Mechanisms of neuronal death in disease: defining the models and the players
Ribe, E. M., Serrano-Saiz, E., Akpan, N., & Troy, C. M. (2008) · Biochemical Journal · doi:10.1042/bj20081118 · Cited by 101 · cited 15×
“see (Ribe et al. 2008; Ribe Garrido et al. 2009)], while common players in necrotic cell death, irrespective of the stimulus, are calcium and ROS (Vanlangenakker et al.”
BackgroundInfluentialBelinson, H., Lev, D., Masliah, E., & Michaelson, D. M. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.5633-07.2008 · Cited by 101 · cited 2×
“ApoE4 and Ab aggregates were found to act synergistically to induce neurodegeneration in the mouse brain (Belinson et al. 2008), whereas Ab accumulation induced by mutant APP did not (Muller et al.”
BackgroundQuilty, M. C., King, A. E., Gai, W.-P., Pountney, D. L., West, A. K., Vickers, J. C., & Dickson, T. C. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2005.10.018 · Cited by 101 · cited 2×
“1)-positive microglia are involved in neuroprotection in PD and DLB (Power and Blumbergs 2009). aSyn is upregulated in a subset of neurons in response to chronic OS and is associated with neuroprotection from relatively low levels of OS (Quilty et al. 2006).”
BackgroundProtein Folding and Misfolding on Surfaces
Stefani, M. (2008) · International Journal of Molecular Sciences · doi:10.3390/ijms9122515 · Cited by 100 · cited 2×
“…of newly synthesized proteins, (f) abnormal proteolytic cleavage, (g) improper expression or altered gene splicing, (h) insufficient molecular chaperone activity, (i) impaired intracellular transport of proteins, and (j) protein folding and misfolding may be modified on surfaces (Stefani 2008).”
BackgroundIntranuclear Degradation of Polyglutamine Aggregates by the Ubiquitin-Proteasome System
Iwata, A., Nagashima, Y., Matsumoto, L., Suzuki, T., Yamanaka, T., Date, H., Deoka, K., Nukina, N., & Tsuji, S. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m809739200 · Cited by 100 · cited 2×
“Intracellular degradation of polyQ aggregates by the UPS is triggered by some nuclear Ub ligases (Iwata et al. 2009), and in inclusion bodies are suggested to have a protective cellular response to mhtt mediated in part by improving intracellular protein degradation related to impairment of UPS…”
BackgroundLiaisons dangereuses: autophagy, neuronal survival and neurodegeneration
Tooze, S. A., & Schiavo, G. (2008) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2008.09.015 · Cited by 100 · cited 1×
“However, how autophagy protects cells from damage leading to ND is not yet clear (Tooze and Schiavo 2008).”
BackgroundCell Death by Necrosis, a Regulated Way to Go
Henriquez, M., Armisen, R., Stutzin, A., & Quest, A. (2008) · Current Molecular Medicine · doi:10.2174/156652408784221289 · Cited by 100 · cited 2×
“…an accidental and uncontrolled mode of cell death, which exhibits rapid cell swelling and subsequent rupture of the plasma membrane that, due to an inflammatory response, usually induces substantial secondary cell damage in the surrounding tissue (Golstein and Kroemer 2007; Henriquez et al. 2008).”
BackgroundMishra, A., Godavarthi, S. K., Maheshwari, M., Goswami, A., & Jana, N. R. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806804200 · Cited by 99 · cited 2×
“The Ub ligase E6-AP is recruited to aggresomes in response to proteasome inhibition and may be involved in the ubiquitination of Hsp70bound misfolded proteins (Mishra et al. 2009).”
BackgroundFujishiro, H., Tsuboi, Y., Lin, W.-L., Uchikado, H., & Dickson, D. W. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0383-1 · Cited by 99 · cited 2×
“2008), probably generated by the same stimulus with the outcome possibly having an inverse relationship depending on genetic background or possibly environmental factors (Fujishiro et al. 2008; Jellinger 2007b).”
BackgroundTau oligomerization: a role for tau aggregation intermediates linked to neurodegeneration
Sahara, N., Maeda, S., & Takashima, A. (2008) · Current Alzheimer Research · doi:10.2174/156720508786898442 · Cited by 99 · cited 2×
“Oligomeric and pre-aggregated forms of tau protein have been shown to be toxic in vitro (Khlistunova et al. 2006), but the mechanisms underlying its structural changes leading to human tauopathies still remain elusive (Brunden et al. 2008; Sahara et al. 2008).”
BackgroundApoptotic signals within the basal forebrain cholinergic neurons in Alzheimer's disease
Wu, C., Thal, L. J., Pizzo, D. P., Hansen, L., Masliah, E., & Geula, C. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2005.06.020 · Cited by 98 · cited 1×
“Recent studies suggest relationships between loss of CB, Fas-associated death domain (FADD) enzyme expression, and phosphorylation of tau within the basal forebrain cholinergic neurons in AD (Wu et al. 2005).”
BackgroundThe two-fold aspect of the interplay of amyloidogenic proteins with lipid membranes
Relini, A., Cavalleri, O., Rolandi, R., & Gliozzi, A. (2008) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2008.11.003 · Cited by 98 · cited 2×
“Lipid surfaces promote aggregation of Ab proteins and the permeability changes that these aggregates induce on lipid membranes (Relini et al. 2009), but there is a dynamic relationship between intra- and extracellular pools of Ab (Oddo et al. 2006).”
BackgroundDetecting Morphologically Distinct Oligomeric Forms of α-Synuclein
Emadi, S., Kasturirangan, S., Wang, M. S., Schulz, P., & Sierks, M. R. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806559200 · Cited by 98 · cited 2×
“2009) and methods to detect morphologically distinct oligomeric forms of aSyn have been described (Emadi et al. 2009).”
BackgroundSignal Transduction Cascades Associated with Oxidative Stress in Alzheimer's Disease
Petersen, R. B., Nunomura, A., Lee, H.-G., Casadesus, G., Perry, G., Smith, M. A., & Zhu, X. (2007) · Journal of Alzheimer's Disease · doi:10.3233/jad-2007-11202 · Cited by 97 · cited 3×
“Keywords Neurodegeneration Classification of proteinopathies Pathogenic factors Oxidative stress Bioenergetic deficiency Mitochondrial defects Neuronal dysfunction/death Abbreviations 8-HOG 8-Hydroxydeoxyguanosine ABAD Ab-binding dehydrogenase Ab b-Amyloid ACD Autophagic cell death AChR Acetylcholine receptor AD Alzhe…”
BackgroundZhao, M., Su, J., Head, E., & Cotman, C. W. (2003) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.07.006 · Cited by 97 · cited 1×
“Accumulation of caspase cleaved APP represents an early neurodegenerative event in aging and AD (Zhao et al. 2003).”
BackgroundSchwartz, M., London, A., & Shechter, R. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.12.013 · Cited by 97 · cited 2×
“…system and the local and systemic immune system will be important for the understanding of pathogenic mechanisms of ND (Piehl and Olsson 2009) and the role of innate ‘‘protective autoimmunity’’ (Schwartz et al. 2009) and of reparative functions of autoimmunity in NDDs (Graber and Dhib-Jalbut 2009).”
BackgroundClinical correlates of mitochondrial function in Huntington's disease muscle
Turner, C., Cooper, J. M., & Schapira, A. H. V. (2007) · Movement Disorders · doi:10.1002/mds.21540 · Cited by 97 · cited 1×
“Biochemical lesions include impaired complex II and III activity in basal ganglia, while ultrastructural studies of cortical biopsies of HD patients showed abnormal mitochondria (Lin and Beal 2006; Turner et al. 2007).”
BackgroundMitochondria and Neurodegeneration
Beal, M. F. (2007) · Novartis Foundation Symposia · doi:10.1002/9780470725207.ch13 · Cited by 97 · cited 2×
“…disturb cell function, cause mtDNA damage, sensitize cells to neurotoxic insults and may initiate cell death, all significant phenomena in the pathogenesis of NDDs (Andersen 2004; Beal 2007; Mancuso et al. 2008a; Maracchioni et al. 2007; Schapira 2008; Weissman et al. 2007; Yang et al. 2008b).”
BackgroundNeuroferritinopathy: Missense mutation in FTL causing early-onset bilateral pallidal involvement
Maciel, P., Cruz, V. T., Constante, M., Iniesta, I., Costa, M. C., Gallati, S., Sousa, N., Sequeiros, J., Coutinho, P., & Santos, M. M. (2005) · Neurology · doi:10.1212/01.wnl.0000178224.81169.c2 · Cited by 96 · cited 2×
“Conditions such as neuroferritinopathy (Maciel et al. 2005; Mancuso et al. 2005) and Friedreich ataxia (FRDA) are associated with mutations in genes that encode proteins involved in iron metabolism, and as the brain ages, iron accumulates in regions that are affected by AD and PD (Altamura and Muckenthaler 2009; Gerla…”
BackgroundDNA strand breaks, neurodegeneration and aging in the brain
Katyal, S., & McKinnon, P. J. (2008) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2008.03.008 · Cited by 96 · cited 2×
“Mitochondrial dysfunction in Alzheimer and Parkinson disease There is evidence of impaired DNA repair in both the aging brain and AD (Katyal and McKinnon 2008), suggesting that this may play a role in AD pathogenesis (Coppede and Migliore 2009).”
BackgroundInterleukins, Inflammation, and Mechanisms of Alzheimer's Disease
Weisman, D., Hakimian, E., & Ho, G. J. (2006) · Vitamins & Hormones · doi:10.1016/s0083-6729(06)74020-1 · Cited by 95 · cited 2×
“…of radicals and peroxynitrite attack have been detected in postmortem AD brain, which, at least in part, are produced by activated microglia, and, together with anomalous release of cytokines, may be a progression factor in AD (Block et al. 2007; Maccioni et al. 2009; Weisman et al. 2006).”
BackgroundObi, K., Akiyama, H., Kondo, H., Shimomura, Y., Hasegawa, M., Iwatsubo, T., Mizuno, Y., & Mochizuki, H. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.11.019 · Cited by 95 · cited 1×
“Interactions between Ab, aSyn and tau may be a molecular mechanism in overlapping pathology of AD and PD/DLB (Mandal et al. 2006; Obi et al. 2008), probably generated by the same stimulus with the outcome possibly having an inverse relationship depending on genetic background or possibly…”
BackgroundIs the ubiquitin-proteasome system impaired in Huntington’s disease?
Ortega, Z., Díaz-Hernández, M., & Lucas, J. J. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7222-8 · Cited by 95 · cited 1×
“HD is linked to global changes in the UPS to a much greater extent than previously recognized, but the global status of the system in HD brain is not yet fully elucidated (Bennett et al. 2007; Ortega et al. 2007).”
BackgroundShaikh, S., & Nicholson, L. F. B. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21644 · Cited by 94 · cited 2×
“Cross-linking of aSyn by AGEs in PD and in incidental LB disease, suggests that AGE-promoted LB formation may reflect early disease-specific changes, accelerating inclusion body formation (Shaikh and Nicholson 2008).”
BackgroundUbiquitin–proteasome system as a modulator of cell fate
Thompson, S. J., Loftus, L. T., Ashley, M. D., & Meller, R. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2007.09.010 · Cited by 94 · cited 3×
“UPS in neurodegenerative disorders Aberrant UPS function has been reported in multiple neuropathologies, including ND and ischemia (Thompson et al. 2008).”
BackgroundDegenerative Diseases of the Nervous System
(2008) · Clinical Neurology · doi:10.1201/b17272-18 · Cited by 94
Olivares, D., Huang, X., Branden, L., Greig, N. H., & Rogers, J. T. (2009) · International Journal of Molecular Sciences · doi:10.3390/ijms10031226 · Cited by 93 · cited 1×
“…PD, many biochemical changes indicate compromised antioxidant systems suggested to underlie cellular vulnerability to progressive OS which generates excessive ROS or free radicals in SN with subsequent cell damage (see Jellinger 2007a; Linert et al. 2006; Miller et al. 2009; Olivares et al. 2009).”
BackgroundLipoperoxidation Is Selectively Involved in Progressive Supranuclear Palsy
Odetti, P., Garibaldi, S., Norese, R., Angelini, G., Marinelli, L., Valentini, S., Menini, S., Traverso, N., Zaccheo, D., Siedlak, S., et al. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.5.393 · Cited by 93 · cited 1×
“Production of lipid peroxidation, e.g., HNE and malondialdehyde is increased in both AD and PSP and its occurrence is proportional to the extent of tau pathology (Odetti et al. 2000).”
BackgroundStrehlow, A. N. T., Li, J. Z., & Myers, R. M. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddl467 · Cited by 92 · cited 1×
“Htt has a role in protein trafficking between the Golgi and the extracellular space (Strehlow et al. 2007).”
BackgroundCD4+ T cells mediate cytotoxicity in neurodegenerative diseases
Appel, S. H. (2008) · Journal of Clinical Investigation · doi:10.1172/jci38096 · Cited by 91 · cited 2×
“…infiltration, and blood–brain-barrier (BBB) dysfunction are prominent pathological features in the pathogenesis and progression of NDDs including AD (Appel 2009; Eikelenboom et al. 2006; McGeer and McGeer 2005; Rojo et al. 2008; Schwab and McGeer 2008; Stolp and Dziegielewska 2009; Zilka et…”
BackgroundScheper, W., & Hoozemans, J. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709787458506 · Cited by 90 · cited 3×
“in the ER are important in the pathogenesis of NDDs (Scheper and Hoozemans 2009).”
BackgroundInfluentialDamage control: DNA repair, transcription, and the ubiquitin–proteasome system
Daulny, A., & Tansey, W. P. (2009) · DNA repair · doi:10.1016/j.dnarep.2009.01.017 · Cited by 90
The Role of Autophagy in Age-Related Neurodegeneration
McCray, B. A., & Taylor, J. P. (2008) · Neurosignals · doi:10.1159/000109761 · Cited by 90 · cited 2×
“Both were implicated to play important roles in the pathogenesis of NDDs (McCray and Taylor 2008), but also to collaborate in neuroprotection (Nedelsky et al.”
BackgroundOxidative RNA Damage and Neurodegeneration
Nunomura, A., Moreira, P., Takeda, A., Smith, M., & Perry, G. (2007) · Current Medicinal Chemistry · doi:10.2174/092986707782794078 · Cited by 90 · cited 1×
“In a variety of tissues, cumulative OS, disrupted mitochondrial respiration, and oxidative mitochondrial damage are associated with, and may promote cell death and degeneration (Halliwell 2006; Nunomura et al. 2007; Yang et al. 2008b).”
BackgroundFailure of protein quality control in amyotrophic lateral sclerosis
Kabashi, E., & Durham, H. D. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.06.006 · Cited by 90 · cited 1×
“The two principal hypotheses on the pathogenesis of ALS are: (a) oxidative damage stemming from aberrant SOD1 redox chemistry, and (b) misfolding of the mutant protein (Kabashi and Durham 2006; Rakhit and Chakrabartty 2006).”
BackgroundBrain proteasomal function in sporadic Parkinson's disease and related disorders
Furukawa, Y., Vigouroux, S., Wong, H., Guttman, M., Rajput, A. H., Ang, L., Briand, M., Kish, S. J., & Briand, Y. (2002) · Annals of Neurology · doi:10.1002/ana.10207 · Cited by 89 · cited 6×
“AD) aSyn multiplication, no relation to UCHL1 aSyn Multiple system atrophy (MSA) ? aSyn MSA-P aSyn MSA-C aSyn Hallervorden–Spatz disease (HSD), pantothenate kinase-associated neurodegeneration PANK2 20 Pantothenate kinase Table 1 continued Disease Mutated gene Chromosome Toxic protein 3 (b) a-Synucleinopathies, variab…”
BackgroundInfluentialAbnormalities of the nucleus and nuclear inclusions in neurodegenerative disease: a work in progress
Woulfe, J. M. (2007) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2006.00819.x · Cited by 88 · cited 5×
“A key unanswered question is whether these aggregates contribute to the onset and progression of ND are mere bystanders resulting from an alternative pathway, or even may be a neuroprotective response (Jellinger 2007b; Schulz 2008; Woulfe 2007).”
BackgroundInfluentialNeurodegenerative Diseases and Metal Ions
Sigel, A., Sigel, H., & Sigel, R. K. O. (2006) · Wiley eBooks · doi:10.1002/0470028114 · Cited by 86
Oxidative stress induces macroautophagy of amyloid β-protein and ensuing apoptosis
Zheng, L. P., Kågedal, K., Dehvari, N., Benedikz, E., Cowburn, R. F., Marcusson, J. O., & Terman, A. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.10.043 · Cited by 85 · cited 1×
“OS induces macroautophagy of Ab protein and ensuing apoptosis (Zheng et al. 2009).”
BackgroundCaspase-1 activation of caspase-6 in human apoptotic neurons
Guo, H., Petrin, D., Zhang, Y., Bergeron, C., Goodyer, C. G., & LeBlanc, A. C. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401753 · Cited by 85 · cited 2×
“Regulation of protein phosphorylation by kinases and phosphatases is a prerequisite mechanism in the control of the apoptotic cell death program (Guo et al. 2006).”
BackgroundThe Ubiquitin-Proteasome Pathway in Huntington's Disease
Mitra, S. S., & Finkbeiner, S. M. (2008) · The Scientific World JOURNAL · doi:10.1100/tsw.2008.60 · Cited by 84 · cited 1×
“…characterized by striatal degeneration with nuclear inclusions of the truncated ubiquitinated protein huntingtin, chaperones, and proteasomes, where protein quality control regulates polyQ-induced toxicity (Finkbeiner and Mitra 2008; Gil and Rego 2008; Wang et al. 2008; Williams and Paulson 2008).”
BackgroundHu, N.-W., Smith, I. M., Walsh, D. M., & Rowan, M. J. (2008) · Brain · doi:10.1093/brain/awn174 · Cited by 84 · cited 1×
“…derivatives of misfolded proteins may play a pathogenic role (Catalano et al. 2006; Csizmók and Tompa 2009; Gong et al. 2003; Haass and Selkoe 2007; Hu et al. 2008; Irvine et al. 2008; Israeli and Sharon 2009; Kokubo et al. 2005; Lee et al. 2006; Resende et al. 2008; Rowan et al. 2007; Salminen…”
BackgroundNeuronal Apoptosis in Neurodegenerative Diseases: From Basic Research to Clinical Application
Kermer, P., Liman, J., Weishaupt, J. H., & Bähr, M. (2004) · Neurodegenerative Diseases · doi:10.1159/000076665 · Cited by 83 · cited 2×
“…(TUNEL/ISL staining associated with the expression of apoptosis-related proteins (ARPs), oncogenes, and other detectable player involved in the cascade of PCD), have reported variable incidence of apoptotic cell death in NDDs (Fadeel and Orrenius 2005; Jellinger 2006, 2007a, b; Kermer et al. 2004).”
BackgroundSantpere, G., & Ferrer, I. (2009) · Acta Neuropathologica · doi:10.1007/s00401-008-0478-8 · Cited by 83 · cited 3×
“Recent studies showed that oxidative damage affects regions vulnerable to PSP and AGD (Santpere and Ferrer 2009b).”
BackgroundRegulation of p53 family members by the ubiquitin-like SUMO system
Stehmeier, P., & Muller, S. (2009) · DNA repair · doi:10.1016/j.dnarep.2009.01.002 · Cited by 83 · cited 3×
“Through a process similar to monoubiquitination termed sumoylation, SUMO monomers are conjugated to target proteins.”
BackgroundInfluentialMuqit, M. M. K. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddh012 · Cited by 82 · cited 2×
“Aggresomes have been reported for superoxide dismutase (SOD) (Son et al. 2003), parkin (Muqit et al. 2004), aSyn (Eliezer 2009a), and prion proteins (Mishra et al. 2003), the formation of which has been associated with activation of caspases and apoptosis (Kristiansen et al. 2005).”
BackgroundProtein misfolding disorders: Pathogenesis and intervention
Gregersen, N. (2006) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-006-0301-4 · Cited by 81 · cited 6×
“However, various factors can result in the cell’s defense machinery becoming overwhelmed such that inspite of aggregates/inclusions cytotoxic species are formed, or cell stresses may have a direct effect on this protein-handling system (Gregersen 2006).”
BackgroundInfluentialMitochondrial dynamics and neurodegeneration
Lu, B. (2009) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-009-0032-7 · Cited by 80 · cited 2×
“Although the molecular basis underlying the decline in mitochondrial function is not really understood, recent experimental evidence has shed some light on the pivotal role of mitochondrial morphology control and dysregulated mitochondrial fusion and fission events in the process of ND (Frank 2006; Lu 2009).”
BackgroundMicroglial Activation Induced by Neurodegeneration
Zhou, Y., Wang, Y., Kovacs, M., Jin, J., & Zhang, J. (2005) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m500114-mcp200 · Cited by 79 · cited 1×
“Recent research revealed numerous novel proteins that may be important in ND-mediated microglia activation in PD (Zhou et al. 2005).”
BackgroundDomenico, F. D., Cenini, G., Sultana, R., Perluigi, M., Uberti, D., Memo, M., & Butterfield, D. A. (2009) · Neurochemical Research · doi:10.1007/s11064-009-9924-9 · Cited by 77 · cited 1×
“Glutathionylation of the proapoptotic protein p53 may prevent the formation of tetramer, an aggregative form required for effective action of p53 and may be involved in OS conditions and ND in AD (Di Domenico et al. 2009).”
BackgroundGhezzi, D., Viscomi, C. F., Ferlini, A., Gualandi, F., Mereghetti, P., DeGrandis, D., & Zeviani, M. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddn441 · Cited by 77 · cited 1×
“Paroxysmal nonkinesigenic dyskinesia (PNKD), an autosomal-dominant movement disorder, is due to a novel disease mechanism based on a deleterious action of the myofibrillogenesis regulator-1 (MR-1) gene (Ghezzi et al. 2009).”
BackgroundSu, J. H., Kesslak, P. J., Head, E., & Cotman, C. W. (2002) · Acta Neuropathologica · doi:10.1007/s00401-002-0548-2 · Cited by 76 · cited 2×
“…with tau, suggesting a ‘‘pretangle’’ stage (Bancher et al. 1989), and the demonstration of elevated casein kinase 1 (CK-1) in both granulovacuolar bodies and NFT-bearing neurons and the co-localization of a cleavage product of APP suggest a link between both these lesions (Su et al. 2002).”
BackgroundModelling Parkinson‐like neurodegeneration via osmotic minipump delivery of MPTP and probenecid
Alvarez‐Fischer, D., Guerreiro, S., Hunot, S., Saurini, F., Marien, M., Sokoloff, P., Hirsch, E. C., Hartmann, A., & Michel, P. P. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05651.x · Cited by 75 · cited 2×
“2005), which were not reproduced by others (Alvarez-Fischer et al. 2008), while subacute rotenone treatment of SH-SY5Y neuroblastoma cells reproduced Lewy neurites but not LB inclusions, reduces mitochondrial movement and slowly killed neural cells (Borland et al.”
BackgroundResultThe ubiquitin-proteasome pathway in cell cycle control
Reed, S. I. (2006) · Springer eBooks · doi:10.1007/b136681 · Cited by 74 · cited 1×
“The UPS is active in distinct nuclear domains and plays a major role controlling the initial steps of gene expression, DNA repair, nuclear quality-control mechanisms, and cell cycle control (Reed 2006).”
BackgroundChallenges in Neuronal Apoptosis
Jellinger, K. (2006) · Current Alzheimer Research · doi:10.2174/156720506778249434 · Cited by 74 · cited 9×
“Whether PCD actually occurs within the human PD brain remains controversial, and this possibility has been neither confirmed by numerous studies nor definitely excluded (Jellinger 2006; Tatton et al. 2003).”
BackgroundResultInfluentialSelf-citationLi, W., Hoffman, P. N., Stirling, W., Price, D. L., & Lee, M. K. (2004) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02166.x · Cited by 73
Mishra, R. S., Bose, S., Gu, Y., Li, R., & Singh, N. (2003) · Journal of Alzheimer s Disease · doi:10.3233/jad-2003-5103 · Cited by 72 · cited 2×
“2004), aSyn (Eliezer 2009a), and prion proteins (Mishra et al. 2003), the formation of which has been associated with activation of caspases and apoptosis (Kristiansen et al.”
BackgroundDysregulation of mitochondrial fusion and fission: an emerging concept in neurodegeneration
Frank, S. (2006) · Acta Neuropathologica · doi:10.1007/s00401-005-0002-3 · Cited by 72 · cited 2×
“Although the molecular basis underlying the decline in mitochondrial function is not really understood, recent experimental evidence has shed some light on the pivotal role of mitochondrial morphology control and dysregulated mitochondrial fusion and fission events in the process of ND (Frank 2006; Lu 2009).”
BackgroundUpdate on the pathogenesis of Parkinson’s disease
Schulz, J. B. (2008) · Journal of Neurology · doi:10.1007/s00415-008-5011-4 · Cited by 71 · cited 1×
“A key unanswered question is whether these aggregates contribute to the onset and progression of ND are mere bystanders resulting from an alternative pathway, or even may be a neuroprotective response (Jellinger 2007b; Schulz 2008; Woulfe 2007).”
BackgroundUbiquitin–proteasome system dysfunction in Parkinson’s disease: current evidence and controversies
Lim, K.-L. (2007) · Expert Review of Proteomics · doi:10.1586/14789450.4.6.769 · Cited by 71 · cited 1×
“While dysfunction of the UPS has already been implicated in the pathogenesis of PD (Lim 2007), the demonstration that aSyn is degraded by both proteasome and autophagy indicates a possible linkage between the UPS and ALP, and the fact that mutated aSyn inhibits ALP functioning by binding to the…”
BackgroundSawada, M., Sawada, H., & Nagatsu, T. (2008) · Neurodegenerative Diseases · doi:10.1159/000113717 · Cited by 70 · cited 1×
“Activated microglia may be both neurotoxic and neuroprotective, depending on several factors including aging, but the causes for transformation between the two actions remains largely unknown (Block and Hong 2005; Sawada et al. 2008).”
BackgroundMeli, G., Visintin, M., Cannistraci, I., & Cattaneo, A. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.01.061 · Cited by 70 · cited 2×
“2008) and is recognized and targeted by conformationsensitive antibodies (Meli et al. 2009).”
BackgroundMAPT S305I mutation: implications for argyrophilic grain disease
Kovács, G. G., Pittman, A. M., Révész, T., Luk, C. Y., Lees, A. J., Kiss, É., Tariska, P., László, L., Molnár, K., Molnár, M. J., et al. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0322-6 · Cited by 70 · cited 1×
“? a Kovacs et al. 2008; b Forman et al. 2007, Liscic et al. 2008, Neumann et al. 2009b; c Farrer et al. 2009; d Kwiatkowski et al. 2009; e Rollinson et al. 2009; f Sreedharan and Shaw 2009 misfolded proteins with formation of high-ordered insoluble fibrils are common pathological hallmarks of many,…”
BackgroundProtective autoimmunity in the nervous system
Graber, J. J., & Dhib-Jalbut, S. S. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.10.001 · Cited by 69 · cited 2×
“…system and the local and systemic immune system will be important for the understanding of pathogenic mechanisms of ND (Piehl and Olsson 2009) and the role of innate ‘‘protective autoimmunity’’ (Schwartz et al. 2009) and of reparative functions of autoimmunity in NDDs (Graber and Dhib-Jalbut 2009).”
BackgroundSelective vulnerability in Alzheimer's disease: Amyloid precursor protein and p75NTR interaction
Fombonne, J., Rabizadeh, S., Banwait, S., Mehlen, P., & Bredesen, D. E. (2009) · Annals of Neurology · doi:10.1002/ana.21578 · Cited by 69 · cited 2×
“The selective vulnerability is putatively caused by their expression of the cell death mediator p75(NTR) (the common NTF receptor), and its interaction with proapoptotic ligands and APP (Fombonne et al. 2009).”
BackgroundProtein misfolding inside cells: The case of huntingtin and Huntington's disease
Hatters, D. M. (2008) · IUBMB Life · doi:10.1002/iub.111 · Cited by 68 · cited 2×
“plays in disease is not yet fully determined (Hatters 2008).”
BackgroundSelective Accumulation of Aggregation-Prone Proteasome Substrates in Response to Proteotoxic Stress
Salomons, F. A., Menéndez-Benito, V., Böttcher, C., McCray, B. A., Taylor, J. P., & Dantuma, N. P. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01485-08 · Cited by 68 · cited 1×
“A reduction in its efficacy increases the storage of aggregation-prone proteins and could explain the accumulation of Ub and substrates in diseased neurons, which disrupt normal cell activity (Bedford et al. 2008b; Salomons et al. 2009; Tai and Schuman 2008).”
BackgroundPhagocytosis of apoptotic cells: a matter of balance
de Almeida, C. J. G., & Linden, R. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-4511-y · Cited by 66 · cited 1×
“Eventually, the cell breaks into small membranesurrounded fragments (apoptotic bodies), which are cleared by phagocytosis in vivo without inciting an inflammatory response (Wyllie 1997), phagocytotic activity being balanced by positive and negative signals (de Almeida and Linden 2005).”
BackgroundMolecular dissection of Alzheimer's disease neuropathology by depletion of serum amyloid P component
Kolstoe, S. E., Ridha, B. H., Bellotti, V., Wang, N., Robinson, C. V., Crutch, S. J., Keir, G., Kukkastenvehmas, R., Gallimore, J. R., Hutchinson, W. L., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902640106 · Cited by 66 · cited 2×
“Its structure and its likely ligand on hyperphosphorylated tau have been solved recently, but the effects of SAP depletion in AD and other NDDs need further elucidation (Kolstoe et al. 2009).”
BackgroundCaspases as therapeutic targets in Alzheimer's disease: is it time to "cut" to the chase?
Rohn, T. T., & Head, E. (2009) · PubMed Central · Cited by 63
Mitochondria, Mitochondrial DNA and Alzheimers Disease. What Comes First?
Mancuso, M., Orsucci, D., Siciliano, G., & Murri, L. (2008) · Current Alzheimer Research · doi:10.2174/156720508785908946 · Cited by 63 · cited 2×
“…disturb cell function, cause mtDNA damage, sensitize cells to neurotoxic insults and may initiate cell death, all significant phenomena in the pathogenesis of NDDs (Andersen 2004; Beal 2007; Mancuso et al. 2008a; Maracchioni et al. 2007; Schapira 2008; Weissman et al. 2007; Yang et al. 2008b).”
BackgroundNewman, J., Rissman, R. A., Sarsoza, F. M., Kim, R. C., Dick, M. B., Bennett, D. A., Cotman, C. W., Rohn, T. T., & Head, E. (2005) · Acta Neuropathologica · doi:10.1007/s00401-005-1027-3 · Cited by 63 · cited 1×
“…or not they are involved or may interact with one another in the neuronal cell death cascade in various neurodegenerative processes is a matter of discussion (Cotman et al. 2005; Gorman 2008; Jellinger 2007a, b; Newman et al. 2005; Ribe et al. 2008; Spires-Jones et al. 2009; Welchman et al. 2005).”
BackgroundCentral Role of α-Synuclein Oligomers in Neurodegeneration in Parkinson Disease
Kazantsev, A. G., & Kolchinsky, A. M. (2008) · Archives of Neurology · doi:10.1001/archneur.65.12.1577 · Cited by 62 · cited 1×
“…assembles into highly soluble special oligomers that proceed to insoluble aggregates (Sharon et al. 2003); it is potentially prone to misfold (Uversky 2007) and may lead to neuronal death (Kazantsev and Kolchinsky 2008), but also other modes of toxicity have been proposed (Waxman and Giasson 2008).”
BackgroundGardiner, J., Barton, D., Overall, R., & Marc, J. (2009) · The Neuroscientist · doi:10.1177/1073858408325269 · Cited by 62 · cited 4×
“Neurotrophic support is inversely correlated with OS (Gardiner et al. 2009).”
BackgroundInfluentialProgrammed Cell Death Mechanisms in Neurological Disease
Bredesen, D. (2008) · Current Molecular Medicine · doi:10.2174/156652408784221315 · Cited by 61 · cited 1×
“…of neuronal demise are discussed: apoptosis, a specific form of gene-directed programmed cell death (PCD); (oncotic) necrosis, a passive killing of the cell; and autophagic degeneration [for rev. see (Bredesen et al. 2006; Bredesen 2008; Gorman 2008; Jellinger 2006, 2007a; Okouchi et al. 2007)].”
BackgroundBanoei, M. M., Houshmand, M., Panahi, M. S. S., Shariati, P., Rostami, M., Manshadi, M. D., & Majidizadeh, T. (2007) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-007-9206-5 · Cited by 60 · cited 1×
“The mtDNA may play an essential role in the pathogenesis of the respiratory chain complex activities in NDDs such as HD, that shows multiple mtDNA deletions in over 60% of HD patients, probably caused by CAG repeats instability and mhtt (Banoei et al. 2007).”
BackgroundVicious Cycles Within the Neuropathophysiologic Mechanisms of Alzheimers Disease
Standridge, J. (2006) · Current Alzheimer Research · doi:10.2174/156720506776383068 · Cited by 60 · cited 2×
“which may occur as a result of the toxic action of substances produced during early phases, and soluble oligomers and protofibrillar derivatives of misfolded proteins may play a pathogenic role (Catalano et al. 2006; Csizmók and Tompa 2009; Gong et al. 2003; Haass and Selkoe 2007; Hu et al. 2008; Irvine et al. 2008; I…”
BackgroundFarfel-Becker, T., Vitner, E., Dekel, H., Leshem, N., Enquist, I. B., Karlsson, S., & Futerman, A. H. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp061 · Cited by 59 · cited 1×
“There is no evidence of the UPR in neuronopathic models of Gaucher disease (Farfel-Becker et al. 2009).”
BackgroundMuresan, V., Varvel, N. H., Lamb, B. T., & Muresan, Z. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.2558-08.2009 · Cited by 59 · cited 1×
“Proteolytic cleavage of APP occurs before its sorting into axonal transport vesicles (Muresan et al. 2009).”
BackgroundMultiple cascade effects of oxidative stress on astroglia
Bond, C. E., & Greenfield, S. A. (2007) · Glia · doi:10.1002/glia.20547 · Cited by 58 · cited 1×
“Proteins are initial targets of ROS, and protein radicals generated by ROS can oxidize reduced glutathione (GSH), suggesting that radicals are important for OS, which triggers dysregulation of calcium homeostasis, reactive astrogliosis and other changes observed in ND (Bond and Greenfield 2007).”
BackgroundThe Rotenone model of Parkinsonism — the five years inspection
Höglinger, G. U., Oertel, W. H., & Hirsch, É. C. (2006) · Springer eBooks · doi:10.1007/978-3-211-45295-0_41 · Cited by 57 · cited 2×
“…with rotenone, a pesticide known to inhibit mitochondrial complex I, induces an increase in OS in DAergic neurons, which in turn may facilitate fibrillization of aSyn, does not cause a selective nigrostriatal dopaminergic damage, but rather a more generalized cell death (Hoglinger et al. 2006).”
BackgroundAmyotrophic lateral sclerosis with neuronal intranuclear protein inclusions
Seilhean, D., Takahashi, J., Hachimi, K. H. E., Fujigasaki, H., Lèbre, A.-S., Biancalana, V., Dürr, A., Salachas, F., Hogenhuis, J., de Thé, H., et al. (2004) · Acta Neuropathologica · doi:10.1007/s00401-004-0855-x · Cited by 57 · cited 2×
“…important in amyotrophic lateral sclerosis (ALS) showing skein-like inclusions in motor neurons rich in Ub proteasome and some chaperone proteins (Seilhean et al. 2004), in spinocerebellar ataxias (SCAs), with neuronal intranuclear inclusions containing ataxin-1 and several chaperones (Davies et…”
BackgroundPrada, C. M., Garcia-Alloza, M., Betensky, R. A., Zhang-Nunes, S. X., Greenberg, S. M., Bacskai, B. J., & Frosch, M. P. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.5426-06.2007 · Cited by 56 · cited 5×
“The problems of AD and tg animal models treated by immunotherapy causing plaque removal and increase in severity of cerebral amyloid angiopathy (CAA) (Boche et al. 2008; Boche and Nicoll 2008; Holmes et al. 2008; Prada et al. 2007; Wilcock et al. 2004; Wisniewski and Konietzko 2008) are not discussed here (see Foster…”
BackgroundInfluentialKim, M. J., Chia, I. V., & Costantini, F. (2008) · The FASEB Journal · doi:10.1096/fj.08-113910 · Cited by 56 · cited 1×
“In some cases monoubiquitination or sumoylation may act to protect proteins from Ub-dependent degradation (Kim et al. 2008) and in other cases they appear to trigger polyubiquitination.”
BackgroundUbiquitin binding proteins protect ubiquitin conjugates from disassembly
Hartmann-Petersen, R., Hendil, K. B., & Gordon, C. (2003) · FEBS Letters · doi:10.1016/s0014-5793(02)03874-7 · Cited by 56 · cited 1×
“This protection depends on the Ub-binding domains and may promote degradation of ubiquitinated proteins (Hartmann-Petersen et al. 2003).”
BackgroundSantpere, G., & Ferrer, I. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00173.x · Cited by 56 · cited 3×
“Recent studies showed that oxidative damage affects regions vulnerable to PSP and AGD (Santpere and Ferrer 2009b).”
BackgroundKato, S., Kato, M., Abe, Y., Matsumura, T., Nishino, T., Aoki, M., Itoyama, Y., Asayama, K., Awaya, A., Hirano, A., et al. (2005) · Acta Neuropathologica · doi:10.1007/s00401-005-1019-3 · Cited by 56 · cited 1×
“These findings suggest that the residual ALS neurons showing redox system upregulation would be less susceptible, whereas the breakdown of this redox system at the advanced disease stage accelerates neuronal degeneration and/or death (Kato et al. 2005).”
BackgroundThe ubiquitin proteasome system in Huntington's disease and the spinocerebellar ataxias
Davies, J. E., Sarkar, S., & Rubinsztein, D. C. (2007) · BMC Biochemistry · doi:10.1186/1471-2091-8-s1-s2 · Cited by 56 · cited 2×
“…neurons rich in Ub proteasome and some chaperone proteins (Seilhean et al. 2004), in spinocerebellar ataxias (SCAs), with neuronal intranuclear inclusions containing ataxin-1 and several chaperones (Davies et al. 2007), and neuronal intranuclear inclusion disease [for rev. see (Jellinger 2007a)].”
BackgroundThorpe, J. R., Tang, H., Atherton, J., & Cairns, N. J. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-008-0137-1 · Cited by 55
Dopamine complexes of iron in the etiology and pathogenesis of Parkinson’s disease
ARREGUIN, S., NELSON, P., PADWAY, S., SHIRAZI, M., & PIERPONT, C. (2009) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2008.09.007 · Cited by 55 · cited 2×
“Protein misfolding of sporadic PD has been associated with reactive oxygen species formed as products of O2 reduction by combination of DA and Fe (Arreguin et al. 2009), but also triggers a cerebral tauopathy (Hoglinger et al. 2005).”
BackgroundMolecular Pathogenesis of Alzheimer’s Disease: Reductionist versus Expansionist Approaches
Castellani, R. J., Zhu, X., Lee, H.-G., Smith, M. A., & Perry, G. (2009) · International Journal of Molecular Sciences · doi:10.3390/ijms10031386 · Cited by 54 · cited 1×
“It becomes more apparent that the pathology of AD and other proteinopathies represents effect rather than cause, or at least a host response to injury equaling neuroprotection (Castellani et al. 2008; Castellani et al. 2009).”
BackgroundClearance of Mutant Aggregate-Prone Proteins by Autophagy
Ravikumar, B., Sarkar, S., & Rubinsztein, D. C. (2008) · Methods in Molecular Biology™ · doi:10.1007/978-1-59745-157-4_13 · Cited by 53 · cited 1×
“Induction of autophagy enhances the clearance of both soluble and aggregated forms of the mutant proteins, and protects against toxicity caused by these mutants (Ravikumar et al. 2008).”
BackgroundGantchev, T. G., & Hunting, D. J. (2008) · Journal of Molecular Modeling · doi:10.1007/s00894-008-0296-x · Cited by 53
Neurofilament subunit (NFL) head domain phosphorylation regulates axonal transport of neurofilaments
Yates, D. M., Manser, C., Vos, K. J. D., Shaw, C. E., McLoughlin, D. M., & Miller, C. C. J. (2009) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2008.11.004 · Cited by 53 · cited 1×
“Axonal transport of NFLs is regulated by NFL subunit head domain phosphorylation (Yates et al. 2009).”
BackgroundThe Effects of the Polyglutamine Repeat Protein Ataxin-1 on the UbL-UBA Protein A1Up
Riley, B. E., Xu, Y., Zoghbi, H. Y., & Orr, H. T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406284200 · Cited by 53 · cited 1×
“The UBL is necessary for A1Up’s association with the 19S proteasome and this association is inhibited by mutant polyglutamine repeat ataxin-1 (Riley et al. 2004).”
BackgroundNeurofibrillary degeneration of the Alzheimer-type: an alternate pathway to neuronal apoptosis?
Hamdane, M., Delobel, P., Sambo, A., Smet‐Nocca, C., Bégard, S., Violleau, A., Landrieu, I., Delacourte, A., Lippens, G. M., Flament, S., et al. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00533-1 · Cited by 52 · cited 2×
“Although several survival signals may converge in tau-containing neurons (Hamdane et al. 2003), the altered degradation and pathological aggregation”
BackgroundThe effects of TNF deficiency on age-related cognitive performance
McAfoose, J., Koerner, H., & Baune, B. T. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.10.006 · Cited by 52 · cited 1×
“Proinflammatory cytokine such as TNF play a role in cognitive processes and aging (McAfoose et al. 2009).”
BackgroundDNA Repair Deficiency and Neurodegeneration
Katyal, S., & McKinnon, P. J. (2007) · Cell Cycle · doi:10.4161/cc.6.19.4757 · Cited by 52 · cited 1×
“A decrease in the DNA base excision repair (BER) activity in NDDs suggests that that the brain might be subjected to the double insult of increased DNA damage, as well as deficiencies of DNA repair pathways (Katyal and McKinnon 2007; Martin 2008).”
BackgroundNanoimaging for protein misfolding and related diseases
Lyubchenko, Y. L., Sherman, S., Shlyakhtenko, L. S., & Uversky, V. N. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20989 · Cited by 52 · cited 1×
“Recent advances have provided insight into the detection and characterization of misfolded protein conformations and have identified critically involved intracellular nanomachines and/or multicomponent complexes (Lee et al. 2006; Lyubchenko et al. 2006; Rubinsztein 2006).”
BackgroundGindhart, J. G. (2006) · Briefings in Functional Genomics and Proteomics · doi:10.1093/bfgp/ell002 · Cited by 51 · cited 1×
“Many proteins identified to bind to kinesin-1 act as cargo, cargo receptors and regulators of kinesin-1 activity, and protein–protein interaction domains regulate kinesin-cargo interactions (Gindhart 2006).”
Backgroundα-Synuclein: A potent inducer of tau pathology
Geddes, J. W. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2004.12.002 · Cited by 50 · cited 2×
“Recent results suggest that hydrogen peroxide accumulates during the incubation of Ab or aSyn and hyperphosphorylated tau that show a close interrelationship (Geddes 2005), synergistic action (Mamah et al.”
BackgroundMaracchioni, A., Totaro, A., Angelini, D. F., Di Penta, A., Bernardi, G., Carrì, M. T., & Achsel, T. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04204.x · Cited by 50 · cited 2×
“…disturb cell function, cause mtDNA damage, sensitize cells to neurotoxic insults and may initiate cell death, all significant phenomena in the pathogenesis of NDDs (Andersen 2004; Beal 2007; Mancuso et al. 2008a; Maracchioni et al. 2007; Schapira 2008; Weissman et al. 2007; Yang et al. 2008b).”
BackgroundNeurogenesis and cell cycle‐reactivated neuronal death during pathogenic tau aggregation
Schindowski, K., Belarbi, K., Bretteville, A., Ando, K., & Buée, L. (2008) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2007.00377.x · Cited by 50 · cited 3×
“…TUNEL-positive neurons and ultrastructural features of both apoptosis and necrosis, but no activated caspases were observed (Andorfer et al. 2005; Schindowski et al. 2008b), while in aging PS/APP mice a crosstalk between apoptosis and autophagy was identified, which influences neuronal survival…”
BackgroundIntracellular degradation of misfolded proteins in polyglutamine neurodegenerative diseases
Li, X., He, L., & Li, X. (2008) · Brain Research Reviews · doi:10.1016/j.brainresrev.2008.08.003 · Cited by 50 · cited 1×
“It remains unclear how the UP and autophagy pathways remove misfolded proteins in the different subcellular regions of neurons, where disease proteins become misfolded and aggregated in an age-dependent manner (Li et al. 2008).”
BackgroundPP1 inhibition by Aβ peptide as a potential pathological mechanism in Alzheimer's disease
Vintém, A. P. B., Henriques, A. G., Silva, O. A. B. D. C. E., & Silva, E. F. D. C. E. (2008) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2008.11.001 · Cited by 49 · cited 1×
“Increased Ab production and/or aggregation may lead to abnormal activity of protein phosphate 1 (PP1) and likely contributes to progression of AD (Vintem et al. 2009), while suppression of Ab deposition leads to long-term reduction of AD pathology in Tg2576 mice (Karlnoski et al. 2009).”
BackgroundDisruption of dopamine homeostasis underlies selective neurodegeneration mediated by α‐synuclein
Park, S. S., Schulz, E. M., & Lee, D. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05929.x · Cited by 48 · cited 1×
“Elevated cytoplasmic dopamine is another main feature underlying the early stage of aSyn-mediated ND (Park et al. 2007).”
BackgroundRegulation of DNA repair by parkin
Kao, S. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.03.048 · Cited by 48 · cited 2×
“Parkin plays a role in maintaining mitochondrial homeostasis, improves mitochondrial dysfunction, regulates their remodeling, promotes their autophagy, promotes DNA repair, and protects against genotoxicity (Kao 2009; Mitsui et al. 2008; Narendra et al. 2008; Park et al. 2009; Poole et al. 2008; Van Laar and Berman 20…”
BackgroundInteraction of α‐synuclein and tau genotypes in Parkinson's disease
Mamah, C., Lesnick, T. G., Lincoln, S., Strain, K. J., de Andrade, M., Bower, J. H., Ahlskog, J. E., Rocca, W. A., Farrer, M. J., & Maraganore, D. M. (2005) · Annals of Neurology · doi:10.1002/ana.20387 · Cited by 47 · cited 2×
“…accumulates during the incubation of Ab or aSyn and hyperphosphorylated tau that show a close interrelationship (Geddes 2005), synergistic action (Mamah et al. 2005; Wenning and Jellinger 2005), and induce a mutual fibrillation (Frasier and Wolozin 2004; Giasson et al. 2003; Kotzbauer et al.…”
BackgroundImmunization in Alzheimer's disease: naïve hope or realistic clinical potential?
Foster, J. K., Verdile, G., Bates, K. A., & Martins, R. N. (2008) · Molecular Psychiatry · doi:10.1038/mp.2008.115 · Cited by 47 · cited 1×
“…models treated by immunotherapy causing plaque removal and increase in severity of cerebral amyloid angiopathy (CAA) (Boche et al. 2008; Boche and Nicoll 2008; Holmes et al. 2008; Prada et al. 2007; Wilcock et al. 2004; Wisniewski and Konietzko 2008) are not discussed here (see Foster et al. 2009).”
BackgroundŽilka, N., Korenova, M., & Novák, M. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0499-y · Cited by 47 · cited 3×
“…and blood–brain-barrier (BBB) dysfunction are prominent pathological features in the pathogenesis and progression of NDDs including AD (Appel 2009; Eikelenboom et al. 2006; McGeer and McGeer 2005; Rojo et al. 2008; Schwab and McGeer 2008; Stolp and Dziegielewska 2009; Zilka et al. 2009).”
BackgroundThe role of α-synuclein and tau in neurodegenerative movement disorders
Wenning, G. K., & Jellinger, K. A. (2005) · Current Opinion in Neurology · doi:10.1097/01.wco.0000168241.53853.32 · Cited by 46 · cited 2×
“Recent results suggest that hydrogen peroxide accumulates during the incubation of Ab or aSyn and hyperphosphorylated tau that show a close interrelationship (Geddes 2005), synergistic action (Mamah et al. 2005; Wenning and Jellinger 2005), and induce a mutual fibril-”
BackgroundSelf-citationAggregate Formation in Cu,Zn Superoxide Dismutase-related Proteins
Son, M., Cloyd, C. D., Rothstein, J. D., Rajendran, B., & Elliott, J. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211698200 · Cited by 46 · cited 2×
“Aggresomes have been reported for superoxide dismutase (SOD) (Son et al. 2003), parkin (Muqit et al.”
BackgroundShao, C. Y., Crary, J. F., Rao, C., Sacktor, T. C., & Mirra, S. S. (2006) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/01.jnen.0000218441.00040.82 · Cited by 45 · cited 1×
“…(MPTP) model of parkinsonism (Duka et al. 2006), and the co-location of phospho-tau and aSyn in both NFTs and LBs (Ishizawa et al. 2003; Shao et al. 2006) and the co-occurrence of abnormal deposition of tau, aSyn and TDP-43 in AD, DLB and other NDDs, probably related to genetic factors…”
BackgroundEffects of Ubiquilin 1 on the Unfolded Protein Response
Lu, A., Hiltunen, M. O., Romano, D., Soininen, H. S., Hyman, B. T., Bertram, L., & Tanzi, R. E. (2008) · Journal of Molecular Neuroscience · doi:10.1007/s12031-008-9155-6 · Cited by 44 · cited 1×
“Overexpression of ubiquilin 1 during ER stress exerts a protective effect during the UPR by attenuation induction of C/EBP homologous protein (CHOP) and potentially increases cell viability (Lu et al. 2009).”
BackgroundSarsoza, F., Saing, T., Kayed, R., Dahlin, R., Dick, M., Broadwater-Hollifield, C., Mobley, S., Lott, I., Doran, E., Gillen, D., et al. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0530-3 · Cited by 44
Chapter 3 Autophagic Neuron Death
Uchiyama, Y., Koike, M., Shibata, M., & Sasaki, M. (2009) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(08)04003-2 · Cited by 42 · cited 5×
“Neuronal cell death may exhibit morphologic features of autophagy or necrosis, which differ from that of canonical apoptosis or autophagic vacuolation can precede apoptotic cell death; this argues against the clear distinction between apoptotic and autophagic cell death (ACD) (Gonzalez-Polo et al. 2005; Uchiyama et al…”
BackgroundInfluentialTau Aggregates and Tau Pathology
Hernández, F., & Avila, J. (2008) · Journal of Alzheimer's Disease · doi:10.3233/jad-2008-14414 · Cited by 42 · cited 2×
“The ‘‘toxic oligomer’’ hypothesis is supported by the finding that a single-domain antibody can recognize a common conformational epitope that is displayed by several disease-associated proteins, including b-amyloid (Ab), a-synuclein (aSyn), tau protein, prions, and polyglutamine (polyQ) containing peptides (Hernandez…”
BackgroundExpression and activity of antioxidants in the brain in progressive supranuclear palsy
Cantuti‐Castelvetri, I., Keller-McGandy, C. E., Albers, D. S., Beal, M. F., Vonsattel, J., Standaert, D. G., & Augood, S. J. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02244-8 · Cited by 42 · cited 2×
“, SOD and GSH, in multiple brain areas (Cantuti-Castelvetri et al. 2002), and activated stressrelated proteins, such as SKPK/JNK and p38 SAPK have”
BackgroundIonic liquids promote amyloid formation from α-synuclein
Hwang, H., Choi, H., Kim, H.-K., Jo, D. H., & Kim, T. D. (2008) · Analytical Biochemistry · doi:10.1016/j.ab.2008.12.019 · Cited by 42 · cited 2×
“In AD, Ab inhibits the proteasome and enhances amyloid and tau accumulation (Oddo 2008; Tseng et al. 2008), while ionic liquids promote amyloid formation from aSyn (Hwang et al. 2009).”
BackgroundMitochondrial DNA sequence variation and neurodegeneration
Mancuso, M., Filosto, M., Orsucci, D., & Siciliano, G. (2008) · Human Genomics · doi:10.1186/1479-7364-3-1-71 · Cited by 42 · cited 2×
“…disturb cell function, cause mtDNA damage, sensitize cells to neurotoxic insults and may initiate cell death, all significant phenomena in the pathogenesis of NDDs (Andersen 2004; Beal 2007; Mancuso et al. 2008a; Maracchioni et al. 2007; Schapira 2008; Weissman et al. 2007; Yang et al. 2008b).”
BackgroundHeat shock protein 27 in neuronal survival and neurite outgrowth
Read, D. E., & Gorman, A. M. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.02.114 · Cited by 41
Neurodegenerative diseases and metal ions
Sigel, A., Sigel, H., & Sigel, R. K. O. (2006) · Cited by 41
Hyperphosphorylated tau is a cause of neuronal dysfunction in tauopathy
Takashima, A. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-14403 · Cited by 40 · cited 3×
“…neurotoxicity of early aggregated state (before fibril formation and after hyperphosphorylation), contributing to disruption of neuronal circuits due to synapse loss and eventual cell death (Chun and Johnson 2007; Mondragon-Rodriguez et al. 2009; Spires-Jones et al. 2009; Takashima 2008).”
BackgroundClarimón, J., Molina‐Porcel, L., Gómez‐Isla, T., Blesa, R., Guardia‐Laguarta, C., González‐Neira, A., Estorch, M., Grau, J. M., Barraquer, L., Roig, C., et al. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181927577 · Cited by 40 · cited 9×
“TDP-43 Dementia with Lewy bodies (DLB) with TDP- 43 ? inclusions ?”
BackgroundInfluentialβ‐Synuclein occurs in vivo in lipid‐associated oligomers and forms hetero‐oligomers with α‐synuclein
Israeli, E., & Sharon, R. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05776.x · Cited by 40 · cited 2×
“which may occur as a result of the toxic action of substances produced during early phases, and soluble oligomers and protofibrillar derivatives of misfolded proteins may play a pathogenic role (Catalano et al. 2006; Csizmók and Tompa 2009; Gong et al. 2003; Haass and Selkoe 2007; Hu et al. 2008; Irvine et al. 2008; I…”
BackgroundThe neuronal ubiquitin-proteasome system: Murine models and their neurological phenotype
van Tijn, P., Hol, E. M., van Leeuwen, F. W., & Fischer, D. F. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.03.001 · Cited by 39 · cited 1×
“The UPS, the major non-lysosomal system for regulating protein turnover, and the autophagy–lysosome pathway (ALP) are the two most important mechanisms for regulating protein handling (Layfield and Mayer 2008; Thompson et al. 2008; van Tijn et al. 2008).”
BackgroundUbiquitin associated protein 1 is a risk factor for frontotemporal lobar degeneration
Rollinson, S., Rizzu, P., Sikkink, S., Baker, M., Halliwell, N., Snowden, J., Traynor, B. J., Ruano, D., Cairns, N., Rohrer, J. D., et al. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.01.009 · Cited by 39 · cited 1×
“? a Kovacs et al. 2008; b Forman et al. 2007, Liscic et al. 2008, Neumann et al. 2009b; c Farrer et al. 2009; d Kwiatkowski et al. 2009; e Rollinson et al. 2009; f Sreedharan and Shaw 2009 misfolded proteins with formation of high-ordered insoluble fibrils are common pathological hallmarks of many,…”
BackgroundWang, M. Y., Ross-Cisneros, F. N., Aggarwal, D., Liang, C.-Y., & Sadun, A. A. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0513-4 · Cited by 38 · cited 3×
“Furthermore, it might be possible to reverse polyQ-induced cytotoxicity by preventing mitochondrial fragmentation (Wang et al. 2009a).”
BackgroundUbiquitin dimers control the hydrolase activity of UCH-L3
Setsuie, R., Sakurai, M., Sakaguchi, Y., & Wada, K. (2008) · Neurochemistry International · doi:10.1016/j.neuint.2008.12.013 · Cited by 38 · cited 2×
“two of the deubiquitinating enzymes expressed in the brain, in vivo (Setsuie et al. 2009).”
BackgroundProtein Folding and Misfolding: Neurodegenerative Diseases
Kaptein, R., Ovádi, J., & Orosz, F. (2008) · Focus on structural biology · doi:10.1007/978-1-4020-9434-7 · Cited by 38 · cited 2×
“…are considered multifactorial caused by genetic, environmental, and endogenous factors related to aging, but their pathogenic role and their basic molecular mechanisms are not fully understood (Forman et al. 2004; Jellinger 2003, 2007a; Ovádi and Orosz 2009; Selkoe 2004; Skovronsky et al. 2006).”
BackgroundMetal Ions and Neurodegenerative Disorders
Zatta, P. F. (2003) · WORLD SCIENTIFIC eBooks · doi:10.1142/5298 · Cited by 38
Inflammation in parkinson’s disease: Causative or epiphenomenal?
Hald, A., van Beek, J., & Lotharius, J. (2007) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/1-4020-5688-5_12 · Cited by 37 · cited 2×
“…and proliferation of MHC class II positive microglia releasing pro-inflammatory cytokines, NO, complements, other substances mediating inflammatory reactions, and OS that may be both inducing factors or sequelae of neuronal death (Hald et al. 2007; Hirsch and Hunot 2009; Schwab and McGeer 2008).”
BackgroundProtein Aggregation in Alzheimers Disease and Other Neoropathological Disorders
Dimakopoulos, A. C. (2005) · Current Alzheimer Research · doi:10.2174/1567205052772795 · Cited by 37 · cited 1×
“The pathogenic pathways involve membrane permeabilization through a channel mechanism or hydrophobic interaction of prefibrillary oligomers with various cellular targets (Dimakopoulos 2005).”
BackgroundDinamarca, M. C., Colombres, M., Cerpa, W., Bonansco, C., & Inestrosa, N. C. (2008) · Neurodegenerative Diseases · doi:10.1159/000113687 · Cited by 37 · cited 1×
“They affect the postsynaptic region and hippocampal synaptic plasticity (Dinamarca et al. 2008), and their synaptic accumulation correlates with synaptic loss (Deshpande et al. 2009).”
BackgroundIncrease of cdk5 is related to neurofibrillary pathology in progressive supranuclear palsy
Borghi, R., Giliberto, L., Assini, A., Delacourte, A., Perry, G., Smith, M. A., Strocchi, P., Zaccheo, D., & Tabaton, M. (2002) · Neurology · doi:10.1212/wnl.58.4.589 · Cited by 37 · cited 1×
“In PSP, total Cdk5 protein levels, in contrast to AD, are more than threefold increased and co-localized with tau immunoreactivity, indicating that in PSP this alteration is different from that in AD which may be due to the absence of Ab protein deposition (Borghi et al. 2002).”
BackgroundCerebral Mitochondrial Metabolism in Early Parkinson's Disease
Powers, W. J., Videen, T. O., Markham, J., BLACK, K. J., Golchin, N., & Perlmutter, J. S. (2008) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2008.63 · Cited by 36 · cited 2×
“Reduction of cerebral mitochondrial metabolism is seen in early PD (Powers et al. 2008), but whether mitochondrial dysfunction is a primary or secondary event, or part of a multifactorial pathogenic process remains to be elucidated (Przedborski 2009; Schapira 2009; Vila et al. 2008).”
BackgroundThe tumour suppressor p53 regulates the expression of amyloid precursor protein (APP)
Cuesta, A., Zambrano, A., Royo, M., & Pascual, A. (2009) · Biochemical Journal · doi:10.1042/bj20081793 · Cited by 35 · cited 2×
“The molecular mechanisms of the biochemical cascades of apoptosis involve upstream effectors such as Par-4, p53 (regulating the expression of APP (Cuesta et al. 2009), and pro-apoptotic Bcl-2 family members, which mediate mitochondrial dysfunction and subsequent release of pro-apoptotic proteins,…”
BackgroundTrkA pathway activation induced by amyloid-beta (Abeta)
Bulbarelli, A., Lonati, E., Cazzaniga, E., Re, F., Sesana, S., Barisani, D., Sancini, G., Mutoh, T., & Masserini, M. (2008) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2008.12.006 · Cited by 35 · cited 1×
“Ab may induce the TrkA pathway activation directly by itself or indirectly promotes NGF secretion (Bulbarelli et al. 2009).”
BackgroundBedford, L., Hay, D., Paine, S., Rezvani, N., Mee, M., Lowe, J. S., & Mayer, R. J. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.10.009 · Cited by 35 · cited 2×
“This demonstrates a direct link between dysfunction of the UPS and the neuropathology of PD and that 26S proteasome activity may maintain neuronal homeostasis (Bedford et al. 2008a).”
BackgroundKarlnoski, R. A., Rosenthal, A., Kobayashi, D., Pons, J., Alamed, J., Mercer, M., Li, Q., Gordon, M. N., Gottschall, P. E., & Morgan, D. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.4560-08.2009 · Cited by 34 · cited 2×
“Increased Ab production and/or aggregation may lead to abnormal activity of protein phosphate 1 (PP1) and likely contributes to progression of AD (Vintem et al. 2009), while suppression of Ab deposition leads to long-term reduction of AD pathology in Tg2576 mice (Karlnoski et al. 2009).”
BackgroundMartínez, A., Dalfó, E., Muntané, G., & Ferrer, I. (2007) · Journal of Neural Transmission · doi:10.1007/s00702-007-0800-y · Cited by 34 · cited 1×
“In PSP, increased lipid peroxidation in cerebral cortex (Martinez et al. 2008), increased activity of antioxidant systems, e.g., SOD and GSH, in multiple brain areas (Cantuti-Castelvetri et al. 2002), and activated stress- related proteins, such as SKPK/JNK and p38 SAPK have been described (Ferrer…”
BackgroundKatsuse, O., Lin, W.-L., Lewis, J. M., Hutton, M. L., & Dickson, D. W. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.09.021 · Cited by 34 · cited 1×
“Despite a lack of clear evidence linking tau aggregates to neuronal loss, the presence of a tangle in a neuron is likely to be harmful, leading to changes in axonal transport and loss of synapses (Katsuse et al. 2006).”
BackgroundMitochondria in Parkinson Disease: Back in Fashion With a Little Help From Genetics
Muqit, M. M. K., Gandhi, S., & Wood, N. W. (2006) · Archives of Neurology · doi:10.1001/archneur.63.5.649 · Cited by 34 · cited 1×
“Mitochondrial alterations and OS are important parts of the multifactorial pathogenic process of PD (Henchcliffe and Beal 2008; Muqit et al. 2006; Onyango 2008; Schapira 2008; Vila et al. 2008).”
BackgroundAmyloid Beta Peptide, 4-Hydroxynonenal and Apoptosis
Lovell, M., & Markesbery, W. (2006) · Current Alzheimer Research · doi:10.2174/156720506778249506 · Cited by 33 · cited 1×
“Increasing evidence suggests that OS (Ab, iron/hydrogen peroxide) or neurotoxic by-products of lipid peroxidation (4-hydroxy-2-nonenal, acrolein) damage DNA and lead to programmed cell death in AD (Lovell and Markesbery 2006).”
BackgroundThe role of protein aggregates in neuronal pathology: guilty, innocent, or just trying to help?
Gispert-Sánchez, S., & Auburger, G. W. J. (2006) · Springer eBooks · doi:10.1007/978-3-211-45295-0_18 · Cited by 32 · cited 1×
“On the other hand, larger protein aggregates may be inactive or even represent an inherent protective or defensive mechanism by sequestering or inactivating toxic oligomers and protofibrils (Gispert-Sanchez and Auburger2006; Gregersen 2006).”
BackgroundThe nuclear proteasome and the degradation of oxidatively damaged proteins
Voss, P., & Grune, T. (2006) · Amino Acids · doi:10.1007/s00726-006-0428-5 · Cited by 32 · cited 2×
“, by oxidative injury— proteins that have the potential to induce cellular damage (Pickart 2001; Voss and Grune 2007).”
BackgroundWoodhouse, A., Dickson, T. C., West, A. K., McLean, C. A., & Vickers, J. C. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.11.010 · Cited by 31 · cited 5×
“…may be associated with incomplete cell-cycle activation in neurons, but recent studies comparing AD and normal aging brain, found no significant differences in the expression of apoptosis-related proteins (ARPs) and apoptotic morphology in cerebral cortex (Jellinger 2006; Woodhouse et al. 2006).”
BackgroundResultInfluentialTDP-43 pathology in familial British dementia
Schwab, C., Arai, T., Hasegawa, M., Akiyama, H., Yu, S. Y., & McGeer, P. L. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0514-3 · Cited by 31 · cited 9×
“That, given the robust survivals of neurons with NFTs (Morsch et al. 1999; Schwab et al. 2009) and recent evidence that NFTs in experimental models do not directly correlate with neuron loss (Andorfer et al.”
BackgroundInfluentialGuy, J. R., Shaw, G., Ross‐Cisneros, F. N., Quirós, P. A., Salomão, S. R., Berezovsky, A., Carelli, V., Feuer, W. J., & Sadun, A. A. (2008) · PubMed · Cited by 31
Chromogranin peptides in amyotrophic lateral sclerosis
Schrott‐Fischer, A., Bitsche, M., Humpel, C., Walcher, C. L., Maier, H., Jellinger, K. A., Rabl, W., Glueckert, R., & Marksteiner, J. (2008) · Regulatory Peptides · doi:10.1016/j.regpep.2008.07.009 · Cited by 30 · cited 1×
“The intracellular co-occurrence of SOD1 and chromogranins, constituents of dense core vesicles, in motor neurons suggests a functional interaction between these proteins (Schrott-Fischer et al. 2009).”
BackgroundSelf-citationMPP+ impairs autophagic clearance of alpha-synuclein by impairing the activity of dynein
Cai, Z., Shi, J., Yang, Y., Cao, B., Wang, F., Huang, J., Yang, F. W., Zhang, P., & Liu, C. (2009) · Neuroreport · doi:10.1097/wnr.0b013e32832986c4 · Cited by 30 · cited 1×
“1-Methyl-4-phenylpyridinium (MPP?) impairs autophagic clearance of aSyn by impeding the activity of dynein that is considered to play an important role in the autophagic clearance of aggregate-prone proteins (Cai et al. 2009).”
BackgroundPiwko, R. J., DeMello, R., Gramlich, R., Lasher, W., Osborn, D., Dombek, C., & Porter, K. (2007) · IEEE Power and Energy Magazine · doi:10.1109/mpe.2007.906307 · Cited by 30
Zouambia, M., Fischer, D. F., Hobo, B., De Vos, R. A. I., Hol, E. M., Varndell, I. M., Sheppard, P. W., & Van Leeuwen, F. W. (2008) · PROTEOMICS · doi:10.1002/pmic.200700679 · Cited by 30 · cited 1×
“ATPase subunit 6b (S6b) transcript upregulation may be related to tauopathies, while in synucleinopathies it appears not to be involved (Zouambia et al. 2008).”
BackgroundIncrease in bax expression and apoptosis are associated in Huntington's disease progression
Teles, A. V. F. F., Rosenstock, T. R., Okuno, C. S., Lopes, G. S., Bertoncini, C. R. A., & Smaili, S. S. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.03.062 · Cited by 29 · cited 1×
“In HD and its mouse models, increase in Bax expression is suggested to be related to an apoptotic induction which contributes to the disease progression (Teles et al. 2008).”
BackgroundIntrinsic Disorder in Proteins Associated with Neurodegenerative Diseases
Uversky, V. N. (2008) · Focus on structural biology · doi:10.1007/978-1-4020-9434-7_2 · Cited by 29
Caspase-2: Vestigial Remnant or Master Regulator?
Troy, C. M., & Ribé, E. M. (2008) · Science Signaling · doi:10.1126/scisignal.138pe42 · Cited by 28 · cited 1×
“…a link between the development of Ab and NFT/tau pathologies may be due to caspase activation and cleavage of APP which facilitate production of Ab and by cleavage of tau may initiate or accelerate the development of tangle pathology (Cotman et al. 2005; Rohn and Head 2009; Troy and Ribe 2008).”
BackgroundSpinocerebellar ataxias due to mitochondrial defects
Kaplan, J. (2002) · Neurochemistry International · doi:10.1016/s0197-0186(01)00127-9 · Cited by 28 · cited 2×
“Nuclear DNA-encoded mitochondrial defects FRDA, an autosomal recessive disease, resulting from mutation in the FRDA (PFRDA-1) gene on chromosome 9, which encodes frataxin, a mitochondrially targeted protein (Kaplan 2002).”
BackgroundProtein degradation in Parkinson disease revisited: it’s complex
Li, H., & Guo, M. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38619 · Cited by 28 · cited 1×
“…complex consisting of early-onset familial PD associated Parkin, PINK-1 (also known as PARK-6) and DJ-1 (PARK-7) mutations promotes degradation of un- or mis-folded proteins and may constitute a pathogenic mechanism for recessive forms of inherited PD (Li and Guo 2009; Xiong et al. 2009).”
BackgroundFrackowiak, J., Potempska, A., & Mazur‐Kolecka, B. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0497-0 · Cited by 27 · cited 1×
“Formation of Ab oligomers in brain vascular smooth muscle cells is triggered by transient exposure to iron-induced OS (Frackowiak et al. 2009).”
BackgroundChang, W.-H., Tien, C., Chen, T.-J., Nukina, N., & Hsieh, M. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.03.004 · Cited by 26 · cited 4×
“6 Huntingtin Choreoacanthocytosis (neuroacanthocytosis) CHAC (VPS13A) 9q21 Chorein Spinocerebellar ataxias (SCA), hereditary SCA 1–19, CACNA-1, TBP 3, 6, 8, 11, 12, 14, 19, 22 Ataxin 1–17 Friedreich ataxia (FRDA) PFRDA-1 (FXN) 9q13 Frataxin (GAA [ 66) Machado–Joseph disease (MJD) ? spinocellular ataxia (SCA) type 2 MJ…”
BackgroundInfluentialJellinger, K. A. (2007) · Springer eBooks · doi:10.1007/978-0-387-30377-2_15 · Cited by 25 · cited 10×
“…are considered multifactorial caused by genetic, environmental, and endogenous factors related to aging, but their pathogenic role and their basic molecular mechanisms are not fully understood (Forman et al. 2004; Jellinger 2003, 2007a; Ovádi and Orosz 2009; Selkoe 2004; Skovronsky et al. 2006).”
BackgroundInfluentialSelf-citationNeuronal inclusions in degenerative disorders
Fornai, F., Soldani, P., Lazzeri, G., di Poggio, A. B., Biagioni, F., Fulceri, F., Batini, S., Ruggieri, S. A., & Paparelli, A. (2005) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2004.12.009 · Cited by 24 · cited 19×
“In a genetic mouse model of PD, 26S proteasomal dysfunction in SN neurons triggers ND of the nigrostriatal pathway, and intraneuronal Lewy-like inclusions containing aSyn and Ub in surviving neurons show mitochondria similar to those in early forms of LBs (pale bodies) in PD patients.”
BackgroundResultInfluentialPolyglutamine Diseases and Molecular Chaperones
Kimura, Y., & Kakizuka, A. (2003) · IUBMB Life · doi:10.1080/1521654032000114339 · Cited by 19 · cited 1×
“In polyQ diseases, the effect of chaperones can inhibit or delay htt aggregates, thus modulating ND in various animal models (Hay et al. 2004; Kimura and Kakizuka 2003).”
BackgroundGupta, V. B., Hegde, M. L., & Rao, K. S. J. (2006) · Current Alzheimer Research · doi:10.2174/156720506778249452 · Cited by 19 · cited 1×
“Nevertheless, they have greatly increased our knowledge of the biochemical mechanisms of neuronal cell death in NDDs (Gupta et al. 2006; Ribe et al. 2008).”
BackgroundMondragón‐Rodríguez, S., Basurto‐Islas, G., Binder, L. I., & García‐Sierra, F. (2008) · Future Neurology · doi:10.2217/14796708.4.1.39 · Cited by 18 · cited 1×
“…neurotoxicity of early aggregated state (before fibril formation and after hyperphosphorylation), contributing to disruption of neuronal circuits due to synapse loss and eventual cell death (Chun and Johnson 2007; Mondragon-Rodriguez et al. 2009; Spires-Jones et al. 2009; Takashima 2008).”
BackgroundPiehl, F., & Olsson, T. P. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.08.031 · Cited by 18 · cited 2×
“…between the nervous system and the local and systemic immune system will be important for the understanding of pathogenic mechanisms of ND (Piehl and Olsson 2009) and the role of innate ‘‘protective autoimmunity’’ (Schwartz et al. 2009) and of reparative functions of autoimmunity in NDDs…”
BackgroundMechanisms of Prion Protein Aggregation
Fontaine, S. N., & Brown, D. R. (2009) · Protein and Peptide Letters · doi:10.2174/092986609787049411 · Cited by 18 · cited 1×
“3) (Cairns et al. 2004; Fontaine and Brown 2009; Forman et al. 2004; Soto and Estrada 2008; Takahashi 2008).”
BackgroundGentile, A., Amadoro, G., Corsetti, V., Ciotti, M. T., Serafino, A., & Calissano, P. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-13205 · Cited by 16 · cited 1×
“…is involved in vesicular turnover, synaptic function, neuronal plasticity response, regulation of certain enzymes, transporters and neurotransmitter vesicles, neuronal survival, and can act as molecular chaperone, may be a critical factor of synucleinopathies (Gentile et al. 2008; Uversky 2008).”
BackgroundSolovyan, V. T. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.01.025 · Cited by 16 · cited 1×
“Caspase-independent excision of chromatin loop domains represents a separate cell death pathway, which appears either in parallel or independently from caspase-dependent DNA fragmentation (Solovyan 2007).”
BackgroundAdvances in our Understanding of Neurodegeneration
Jellinger, K. A. (2007) · Elsevier eBooks · doi:10.1016/b978-044452809-4/50142-3 · Cited by 15 · cited 10×
“…are considered multifactorial caused by genetic, environmental, and endogenous factors related to aging, but their pathogenic role and their basic molecular mechanisms are not fully understood (Forman et al. 2004; Jellinger 2003, 2007a; Ovádi and Orosz 2009; Selkoe 2004; Skovronsky et al. 2006).”
BackgroundInfluentialSelf-citationThe Role of Iron in the Pathogenesis of Parkinson's Disease
Gerlach, M., Double, K. L., Götz, M. E., Youdim, M. B. H., & Riederer, P. F. (2006) · Wiley eBooks · doi:10.1002/0470028114.ch6 · Cited by 15 · cited 4×
“…in the SNp with a shift of Fe(II):Fe(III) of 2:1 as compared to 1:2 in controls and loss of soluble aSyn, by its aggregation, can increase dopamine synthesis with accompanying increased generation of reactive metabolites, finally leading to degeneration (Gerlach et al. 2006; Götz et al. 2004).”
BackgroundInfluentialThe Chemical Interplay between Catecholamines and Metal Ions in Neurological Diseases
Linert, W., Jameson, G. N. L., Jameson, R. F., & Jellinger, K. A. (2006) · Wiley eBooks · doi:10.1002/0470028114.ch11 · Cited by 14 · cited 6×
“2005) and Friedreich ataxia (FRDA) are associated with mutations in genes that encode proteins involved in iron metabolism, and as the brain ages, iron accumulates in regions that are affected by AD and PD (Altamura and Muckenthaler 2009; Gerlach et al. 2006; Linert et al. 2006; Zecca et al. 2004).”
BackgroundInfluentialSelf-citationFollowing the leader: fibrillization of ?-synuclein and tau
Frasier, M. A., & Wolozin, B. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.02.008 · Cited by 14 · cited 1×
“…accumulates during the incubation of Ab or aSyn and hyperphosphorylated tau that show a close interrelationship (Geddes 2005), synergistic action (Mamah et al. 2005; Wenning and Jellinger 2005), and induce a mutual fibrillation (Frasier and Wolozin 2004; Giasson et al. 2003; Kotzbauer et al. 2004).”
BackgroundCasademont, J., Rodríguez‐Santiago, B., Miró, Ò., Beato, A., López, S., Nunes, V., & Cardellach, F. (2005) · Aging Clinical and Experimental Research · doi:10.1007/bf03337713 · Cited by 14 · cited 2×
“of respiratory complexes in brain homogenates did not support the primary contribution of mitochondrial respiratory chain dysfunction in AD (Casademont et al. 2005).”
BackgroundMiyoshi, K., Ohyagi, Y., Sakae, N., Motomura, K., Ma, L., Taniwaki, T., Furuya, H., Tabira, T., & Kira, J. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-0989 · Cited by 13 · cited 1×
“PSEN1 mutations, among the major causes of early-onset FAD, have been shown to accelerate the activation of initiator caspases and promote apoptosis, which may be associated, at least in part, with Ab production (Miyoshi et al. 2009).”
BackgroundSynuclein Misfolding and Neurodegenerative Diseases
Uversky, V. N. (2008) · Cited by 13
Protein-Based Neuropathology and Molecular Classification of Human Neurodegenerative Diseases
Kovács, G. G., & Budka, H. (2008) · Focus on structural biology · doi:10.1007/978-1-4020-9434-7_11 · Cited by 10 · cited 3×
“In general, the identity of the underlying protein determines which neurons are affected and, hence, the clinical manifestation of each disease (Kovacs and Budka 2009).”
BackgroundDiwakarla, S., Mercer, L. D., Lee-Kardashyan, L., Chu, P. W. Y., Shin, Y. S., Lau, C. L., Hughes, M. L. R., Nagley, P., & Beart, P. M. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.05937.x · Cited by 10 · cited 1×
“GABAergic striatal neurons exhibit caspase-independent, mitochondrially mediated PCD, reflecting differential interplay between caspase cascade and alternative cell death pathways (Diwakarla et al. 2009).”
BackgroundInhibition of α-Synuclein Aggregation by Antioxidants and Chaperones in Parkinson’s Disease
Rochet, J., & Liu, F. (2008) · Focus on structural biology · doi:10.1007/978-1-4020-9434-7_8 · Cited by 8
Practical Guide to Neurogenetics
Warner, T. T., & Hammans, S. R. (2009) · Elsevier eBooks · doi:10.1016/b978-0-7506-5410-4.x0001-1 · Cited by 8
Cell Death in Parkinson’s Disease
Smeyne, R. J., & Faherty, C. J. (2004) · CRC Press eBooks · doi:10.1201/9780203508596.ch42 · Cited by 8
Nitric Oxide and Cellular Stress Response in Brain Aging and Neurodegenerative Disorders
Calabrese, V., Mancuso, C., Marco, C. M. D., Stella, A. M. G., & Butterfield, D. A. (2007) · Elsevier eBooks · doi:10.1016/b978-044452809-4/50145-9 · Cited by 7 · cited 1×
“Thus, it is a major factor of the cytopathology of many diseases including NDDs and their models (see Calabrese et al. 2007; Fatokun et al. 2008; Gardiner et al. 2009; Halliwell 2006; Nunomura et al. 2009; Petrozzi et al. 2007).”
BackgroundOn the key role played by altered protein conformation in Parkinson’s disease
Agnati, L. F., Baldelli, E., Andreoli, N., Woods, A. S., Vellani, V., Marcellino, D. J., Guidolin, D., & Fuxé, K. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-008-0072-1 · Cited by 7 · cited 1×
“In this case, the loss of function may be accompanied by a gain-of-function (GOF) pathogenesis, which in many cases determines the pathological and clinical features (Agnati et al. 2008; Winklhofer et al. 2008).”
BackgroundEndoplasmic Reticulum Stress in Neurodegeneration
Hoozemans, J. J. M., & Scheper, W. (2008) · Focus on structural biology · doi:10.1007/978-1-4020-9434-7_5 · Cited by 7 · cited 1×
“Although its initial participation in AD pathogenesis might be neuroprotective, its sustained activation might initiate or mediate ND (Hoozemans and Scheper 2009).”
Background
Research works printed but not linked: 2
- Mattson P, Bazan NG (2006) Apoptosis and necrosis. In: Siegel GJ, Albers RW, Brady ST, Price DL (eds) Basic neurochemistry, 7th edn. Elsevier Academic Press, Amsterdam, pp 603–615
- Morfini GA, Stenoien DL, Brady ST (2006) Axonal transport. In: Siegel GJ, Albers RW, Brady ST, Price DL (eds) Basic neurochemistry, 7th edn. Elsevier Academic Press, Amsterdam, pp 485–501
Cited by
KEGG: integrating viruses and cellular organisms
Kanehisa, M., Furumichi, M., Sato, Y., Ishiguro-Watanabe, M., & Tanabe, M. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkaa970 · Cited by 3,436
Microalgae for High-Value Products Towards Human Health and Nutrition
Barkia, I., Saari, N., & Manning, S. R. (2019) · Marine Drugs · doi:10.3390/md17050304 · Cited by 719
“This is supported by the overproduction of ROS in early-stage patients that results in cleaving and misfolding of the amyloid precursor protein to amyloid beta-peptide (Aβ), which induces mitochondrial dysfunction and facilitates the formation of amyloid plaques [230].”
BackgroundPhotoreceptor degeneration: genetic and mechanistic dissection of a complex trait
Wright, A. F., Chakarova, C. F., Abd El-Aziz, M. M., & Bhattacharya, S. S. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2717 · Cited by 631
“Integrating diverse cellular stresses Some themes, such as increased RONS and bioenergetic dysfunction, recur in the PR cell-death mechanisms discussed above, but how do the different mechanisms converge on a final common death pathway? Similar mechanistic themes have been identified for neurodegenerative disorders th…”
Apoptosis and Oxidative Stress in Neurodegenerative Diseases
Radi, E., Formichi, P., Battisti, C., & Federico, A. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-132738 · Cited by 630
Basic mechanisms of neurodegeneration: a critical update
Jellinger, K. A. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01010.x · Cited by 596
“1 Algorithm for classification of neurodegenerative diseases with protein deposits (proteinopathies) (from [1]).”
BackgroundInfluentialSelf-citation
Metadata
- Authors
- Jellinger, K. A.
- Corresponding author
- Jellinger, Kurt A.
- ORCID
- Jellinger, Kurt A.
- Venue
- Journal of Neural Transmission
- Published
- 2009-06-05
- Volume
- 116
- Issue
- 9
- Pages
- 1111-1162
- ISSN
- 0300-9564 (ISSN-L)
- 1435-1463
- OpenAlex
- W2091026347
- Cited by
- 274
- References
- 618
- Citations by year
- 2026: 7 · 2025: 9 · 2024: 12 · 2023: 11 · 2022: 11 · 2021: 13 · 2020: 13 · 2019: 17 · 2018: 10 · 2017: 11 · 2016: 16 · 2015: 13 · 2014: 12 · 2013: 27 · 2012: 23
- FWCI
- 3.36
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Neural Transmission (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- neurodegeneration, proteinopathies, protein misfolding, ubiquitin-proteasome system, autophagy, oxidative stress, mitochondrial dysfunction, Golgi apparatus, molecular chaperones, neurotrophins, neuroinflammation, programmed cell death, amyloid-beta, tau protein, alpha-synuclein, TDP-43, preclinical diagnosis, common pathogenic mechanisms, neurodegenerative disease classification
- MeSH terms
- Free Radicals, Humans, Models, Biological, Mutation, Nerve Tissue Proteins, Protein Folding, Oxidative Stress, Neurodegenerative Diseases, Ubiquitin, Proteasome Endopeptidase Complex
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.